Form 4 Tracker
Merck & Co., Inc.
MRK

73 insider filings · Latest: Aug 13, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Aug 13, 2026Aug 13 9:02 PMChirfi GuindoEVP, Access, Policy & Comms
Sale
10,000$135.00$1.4M36,613.127(D)

View →

Aug 13, 2026Aug 13 8:15 PMCHIRFI GUINDO
Proposed Sale
10,000$135.00$1.4M

View →

Aug 12, 2026Aug 13 8:11 PMJennifer ZacharyEVP, General Counsel
Sale
80,315$133.46$10.7M45,509.254(D)

View →

Aug 12, 2026Aug 12 8:23 PMRICHARD ROBERT DELUCA JR
Proposed Sale
11,699$131.63$1.5M

View →

Aug 12, 2026Aug 12 8:19 PMJENNIFER L ZACHARY
Proposed Sale
80,315$133.46$10.7M

View →

Aug 12, 2026Aug 12 8:10 PMRichard R. DelucaEVP&Pres, Merck Animal Heallth
Sale
11,699$131.63$1.5M110,167.07(D)

View →

Aug 11, 2026Aug 12 8:10 PMRichard R. DelucaEVP&Pres, Merck Animal Heallth
Sale
12,837$131.76$1.7M121,866.07(D)

View →

Aug 10, 2026Aug 12 8:10 PMRichard R. DelucaEVP&Pres, Merck Animal Heallth
Sale
20,784$130.43$2.7M134,703.07(D)

View →

Aug 11, 2026Aug 11 8:14 PMRICHARD ROBERT DELUCA JR
Proposed Sale
12,837$131.76$1.7M

View →

Aug 10, 2026Aug 10 8:43 PMRICHARD ROBERT DELUCA JR
Proposed Sale
20,784$130.43$2.7M

View →

Aug 6, 2026Aug 10 8:28 PMRichard R. DelucaEVP&Pres, Merck Animal Heallth
Sale
6,050$130.38$788.8K155,487.07(D)

View →

Aug 5, 2026Aug 7 8:21 PMDavid R. MaraldoEVP & Pres. MMD
Sale
18,706$128.72$2.4M18,212.434(D)

View →

Aug 5, 2026Aug 7 8:19 PMDavid Michael WilliamsEVP,Chief Info&Digital Officer
Sale
52,847$128.77$6.8M31,716.037(D)

View →

Aug 6, 2026Aug 7 8:17 PMChirfi GuindoEVP, Access, Policy & Comms
Sale
15,000$131.00$2.0M46,613.127(D)

View →

Aug 6, 2026Aug 6 8:47 PMCHIRFI GUINDO
Proposed Sale
15,000$131.00$2.0M

View →

Aug 6, 2026Aug 6 8:45 PMRICHARD ROBERT DELUCA JR
Proposed Sale
6,050$130.38$788.8K

View →

Aug 5, 2026Aug 5 8:27 PMDAVID M WILLIAMS
Proposed Sale
52,847$128.77$6.8M

View →

Aug 5, 2026Aug 5 8:26 PMDAVID MARALDO
Proposed Sale
18,706$128.72$2.4M

View →

Feb 9, 2026Feb 13 9:15 PMCHIRFI GUINDO
Proposed Sale
20,000$118.41$2.4M

View →

Feb 12, 2026Feb 12 9:02 PMChirfi GuindoChief Marketing Officer
Sale
10,000$121.46$1.2M60,615.127(D)

View →

Page 1 of 3

Next →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Apr 30, 2026May 1 9:42 PMBetty D LarsonEVP, Chief HR Officer
Option Exercise
11,35011,350(D)

View →

Apr 29, 2026May 1 9:42 PMBetty D LarsonEVP, Chief HR Officer
Option Exercise
2,0854,172(D)

View →

Apr 29, 2026May 1 9:39 PMCaroline LitchfieldEVP & CFO
Option Exercise
3,9357,870(D)

View →

Apr 29, 2026May 1 9:38 PMRobert M DavisDirector, Chairman, CEO & President
Option Exercise
13,30026,601(D)

View →

Apr 29, 2026May 1 9:34 PMJohannes Jacobus OosthuizenEVP, Oncology & Int?l
Option Exercise
1,3772,755(D)

View →

Mar 31, 2026Apr 1 5:47 PMChristine E SeidmanDirector
Grant/Award
67.54519,238.328(D)

View →

Mar 31, 2026Apr 1 5:44 PMThomas H GlocerDirector
Grant/Award
405.271108,293.493(D)

View →

Mar 31, 2026Apr 1 5:42 PMMary Ellen CoeDirector
Grant/Award
249.39729,702.652(D)

View →

Feb 9, 2026Feb 9 9:01 PMJennifer ZacharyEVP, General Counsel
Option Exercise
121,573$87.100(D)

View →

Feb 6, 2026Feb 6 9:20 PMDavid Michael WilliamsEVP,Chief Info&Digital Officer
Option Exercise
5,0004,600(D)

View →

Feb 4, 2026Feb 6 9:18 PMDalton E. Smart IIISVP Fin. - Global Controller
Option Exercise
4,000$62.078,130(D)

View →

Feb 4, 2026Feb 6 9:13 PMCaroline LitchfieldEVP & CFO
Option Exercise
41,9970(D)

View →

Feb 4, 2026Feb 6 9:12 PMDean Y LiExecutive VP & President, MRL
Option Exercise
15,0870(D)

View →

← Previous

Page 3 of 3